• 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Journal of public health management and practice: JPHMP >Physician compliance with pneumococcal conjugate vaccine shortage recommendations in 2004.
【24h】

Physician compliance with pneumococcal conjugate vaccine shortage recommendations in 2004.

机译：医生在2004年符合肺炎球菌结合疫苗短缺建议。

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

OBJECTIVE: To assess pattern of pneumococcal conjugate vaccine (PCV) administration during periods of vaccine shortage and changing recommendations. METHODS: During 2004 PCV shortages, the Advisory Committee for Immunization Practices recommended delay of doses 3 and 4 (PCV3 and PCV4) to healthy children. A managed care health plan evaluated PCV doses administered to all enrolled children at ages 3, 5, 7, and 16 months in 2004; ICD9 codes were used to identify high-risk children. RESULTS: Immunization coverage for the first two PCV doses remained relatively stable throughout 2004 for both high-risk and healthy children. PCV3 coverage for healthy children dropped significantly from 63 percent preshortage (February 2004) to a low of 7 percent (June 2004), then rose to preshortage levels of 2 months after recommendations were made to resume PCV3 administration. Coverage of high-risk children followed a similar pattern as that for healthy children. PCV4 coverage showed similar declines and increases following shortage-related recommendations as PCV3. Most children whose PCV3 dose may have been delayed during the shortage did receive PCV3 after the shortage. CONCLUSIONS: Providers demonstrated rapid change in PCV administration in response to shortage-related recommendations. Little coverage difference was seen between healthy and high-risk children, possibly due to inadequate ability to determine which children truly are at high risk identified on the basis of ICD9 codes.
机译：目的：评估在疫苗短缺和更改建议期间肺炎球菌结合疫苗（PCV）的给药方式。方法：在2004年PCV短缺期间，免疫实践咨询委员会建议向健康儿童延迟3和4剂量（PCV3和PCV4）的使用。一项有管理的护理健康计划评估了2004年向所有3、5、7和16个月大的入组儿童施用的PCV剂量; ICD9代码用于识别高危儿童。结果：对于高危和健康儿童，前两个PCV剂量的免疫覆盖率在整个2004年保持相对稳定。健康儿童的PCV3覆盖率从短缺前的63％（2004年2月）显着下降到7％的低水平（2004年6月），然后在建议恢复PCV3管理后的两个月内上升到短缺前的水平。高危儿童的覆盖率与健康儿童的覆盖率相似。在与短缺相关的建议之后，PCV4的覆盖率出现了类似的下降和增长，与PCV3相似。在短缺期间可能已延迟PCV3剂量的大多数儿童在短缺后确实接受了PCV3。结论：供应商展示了PCV管理的快速变化，以应对与短缺相关的建议。健康儿童和高风险儿童之间的覆盖率差异很小，这可能是由于根据ICD9代码确定哪些儿童真正处于高风险状态的能力不足而引起的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号